Skip to main content
Log in

Prokaryotic Expression, Refolding and Purification of High-Purity Mouse Midkine in Escherichia coli

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

To evaluate the clinic safety of human Midkine as an articular protective agent, recombinant mouse Midkine (rmMK) was prepared in prokaryotic system for the pre-clinic long-term studies in mice. The open reading frame of mouse Midkine (mMK) was sub-cloned onto expression vector pET30a (+) and transformed into Escherichia coli BL21 (DE3) strain line. The rmMK protein, with a Met fused at N terminus of native mMK for expression initiating, proved to be expressed in inclusion bodies and turned out to be soluble post-denaturation and renaturation. The soluble rmMK was purified successfully with ion exchange and affinity chromatography and characterised good enough to meet the requirements for animal use. Eventually, 13.2-mg rmMK with high quality and bioactivity was obtained from 1 L LB culture, and the total recovery was 11.4 %. The present work laid a good foundation for pilot- or large-scale production of rmMK in prokaryotic system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Kadomatsu, K., Kishida, S., & Tsubota, S. (2013). The heparin-binding growth factor midkine: the biological activities and candidate receptors. Journal of Biochemistry, 153, 511–521.

    Article  CAS  Google Scholar 

  2. Kadomatsu, K., & Muramatsu, T. (2004). Midkine and pleiotrophin in neural development and cancer. Cancer Letters, 204, 127–143.

    Article  CAS  Google Scholar 

  3. Wellstein, A. (2012). ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers. Frontiers in Oncology, 2, 192.

    Article  Google Scholar 

  4. Ikematsu, S., Yano, A., Aridome, K., Kikuchi, M., Kumai, H., Nagano, H., et al. (2000). Serum midkine levels are increased in patients with various types of carcinomas. British Journal of Cancer, 83, 701–706.

    Article  CAS  Google Scholar 

  5. Lucas, S., Reindl, T., Henze, G., Kurtz, A., Sakuma, S., & Driever, P. H. (2009). Increased midkine serum levels in pediatric embryonal tumor patients. Journal of Pediatric Hematology/Oncology, 31, 713–717.

    Article  CAS  Google Scholar 

  6. Ikematsu, S., Nakagawara, A., Nakamura, Y., Ohira, M., Shinjo, M., Kishida, S., et al. (2008). Plasma midkine level is a prognostic factor for human neuroblastoma. Cancer Science, 99, 2070–2074.

    Article  CAS  Google Scholar 

  7. Xu, C., Zhang, Z., Wu, M., Zhu, S., Gao, J., Zhang, J., et al. (2011). Recombinant human midkine stimulates proliferation and decreases dedifferentiation of auricular chondrocytes in vitro. Experimental Biology and Medicine (Maywood, N.J.), 236, 1254–1262.

    Article  CAS  Google Scholar 

  8. Zhang, Z. H., Li, H. X., Qi, Y. P., Du, L. J., Zhu, S. Y., Wu, M. Y., et al. (2010). Recombinant human midkine stimulates proliferation of articular chondrocytes. Cell Proliferation, 43, 184–194.

    Article  CAS  Google Scholar 

  9. Zhang, Z. H., Du, L. J., Xiang, D., Zhu, S. Y., Wu, M. Y., Lu, H. L., et al. (2009). Expression and purification of bioactive high-purity human midkine in Escherichia coli. Journal of Zhejiang University. Science. B, 10, 79–86.

    Article  CAS  Google Scholar 

  10. Murasugi, A., Tohma-Aiba, Y., & Asami, Y. (2000). Production of recombinant human midkine in yeast, Pichia pastoris. Journal of Bioscience and Bioengineering, 90, 395–399.

    Article  CAS  Google Scholar 

  11. Murasugi, A., & Tohma-Aiba, Y. (2003). Production of native recombinant human midkine in the yeast, Pichia pastoris. Protein Expression and Purification, 27, 244–252.

    Article  CAS  Google Scholar 

  12. Murasugi, A., & Tohma-Aiba, Y. (2002). Characterization of partially truncated human midkine expressed in Pichia pastoris. Bioscience Biotechnology and Biochemistry, 66, 1295–1300.

    Article  CAS  Google Scholar 

  13. Inui, T., Bodi, J., Kubo, S., Nishio, H., Kimura, T., Kojima, S., et al. (1996). Solution synthesis of human midkine, a novel heparin-binding neurotrophic factor consisting of 121 amino acid residues with five disulphide bonds. Journal of Peptide Science, 2, 28–39.

    CAS  Google Scholar 

  14. Xiang, D., Zhang, J., Chen, Y., Guo, Y., Schalow, A., Zhang, Z., et al. (2010). Expressions and purification of a mature form of recombinant human Chemerin in Escherichia coli. Protein Expression and Purification, 69, 153–158.

    Article  CAS  Google Scholar 

  15. Malyala, P., & Singh, M. (2008). Endotoxin limits in formulations for preclinical research. Journal of Pharmaceutical Sciences, 97, 2041–2044.

    Article  CAS  Google Scholar 

  16. Qi, M., Ikematsu, S., Maeda, N., Ichihara-Tanaka, K., Sakuma, S., Noda, M., et al. (2001). Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. The Journal of Biological Chemistry, 276, 15868–15875.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Financial support for this work was provided by National Science Foundation of China (Grant No. 81173113 and No. 81273573), Shanghai Science Foundation (Grant No. 11431921300) and National Post-doctor Foundation of China (Grant No. 2012 M520902).

Conflict of Interest

The authors declare that there exist no competing financial or other interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haixia Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, J., Wang, H. Prokaryotic Expression, Refolding and Purification of High-Purity Mouse Midkine in Escherichia coli . Appl Biochem Biotechnol 176, 454–466 (2015). https://doi.org/10.1007/s12010-015-1587-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-015-1587-1

Keywords

Navigation